Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Controlled self-assembly of stomatosomes by use of single-component fluorinated dendritic amphiphiles.

Berlepsch HV, Thota BNS, Wyszogrodzka M, de Carlo S, Haag R, Böttcher C.

Soft Matter. 2018 Jun 27;14(25):5256-5269. doi: 10.1039/c8sm00243f.

PMID:
29888366
2.

Supramolecular Copolymerization as a Strategy to Control the Stability of Self-Assembled Nanofibers.

Thota BNS, Lou X, Bochicchio D, Paffen TFE, Lafleur RPM, van Dongen JLJ, Ehrmann S, Haag R, Pavan GM, Palmans ARA, Meijer EW.

Angew Chem Int Ed Engl. 2018 Jun 4;57(23):6843-6847. doi: 10.1002/anie.201802238. Epub 2018 May 2.

PMID:
29719091
3.

Aggregation Behavior of Non-ionic Twinned Amphiphiles and Their Application as Biomedical Nanocarriers.

Singh AK, Thota BNS, Schade B, Achazi K, Khan A, Böttcher C, Sharma SK, Haag R.

Chem Asian J. 2017 Jul 18;12(14):1796-1806. doi: 10.1002/asia.201700450. Epub 2017 Jun 9.

PMID:
28453907
4.

Crosslinked Redox-Responsive Micelles Based on Lipoic Acid-Derived Amphiphiles for Enhanced siRNA Delivery.

Tschiche A, Thota BN, Neumann F, Schäfer A, Ma N, Haag R.

Macromol Biosci. 2017 Feb;17(2). doi: 10.1002/mabi.201600533. No abstract available.

PMID:
28199066
5.

Crosslinked Redox-Responsive Micelles Based on Lipoic Acid-Derived Amphiphiles for Enhanced siRNA Delivery.

Tschiche A, Thota BN, Neumann F, Schäfer A, Ma N, Haag R.

Macromol Biosci. 2016 Jun;16(6):811-23. doi: 10.1002/mabi.201500363. Epub 2016 Feb 4. Erratum in: Macromol Biosci. 2017 Feb;17 (2):.

PMID:
26847397
6.

Supramolecular Architectures of Dendritic Amphiphiles in Water.

Thota BN, Urner LH, Haag R.

Chem Rev. 2016 Feb 24;116(4):2079-102. doi: 10.1021/acs.chemrev.5b00417. Epub 2015 Dec 16.

PMID:
26669418
7.

Dendronylation: Residue-specific chemoselective attachment of oligoglycerol dendrimers on proteins with noncanonical amino acids.

Ma Y, Thota BN, Haag R, Budisa N.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5247-9. doi: 10.1016/j.bmcl.2015.09.055. Epub 2015 Sep 25.

8.

Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.

Shastry AH, Thota B, Srividya MR, Arivazhagan A, Santosh V.

Pathol Oncol Res. 2016 Apr;22(2):287-92. doi: 10.1007/s12253-015-9928-5. Epub 2015 Aug 9.

PMID:
26253838
9.

Systematic adjustment of charge densities and size of polyglycerol amines reduces cytotoxic effects and enhances cellular uptake.

Hellmund M, Achazi K, Neumann F, Thota BN, Ma N, Haag R.

Biomater Sci. 2015 Nov;3(11):1459-65. doi: 10.1039/c5bm00187k.

PMID:
26244171
10.

P53 stratification reveals the prognostic utility of matrix metalloproteinase-9 protein expression in glioblastoma.

Shastry AH, Thota B, Arimappamagan A, Santosh V.

Neurol India. 2015 May-Jun;63(3):399-404. doi: 10.4103/0028-3886.158227.

11.

Online monitoring the isomerization of an azobenzene-based dendritic bolaamphiphile using ion mobility-mass spectrometry.

Urner LH, Thota BN, Nachtigall O, Warnke S, von Helden G, Haag R, Pagel K.

Chem Commun (Camb). 2015 May 25;51(42):8801-4. doi: 10.1039/c5cc01488c.

PMID:
25916748
12.

Towards engineering of self-assembled nanostructures using non-ionic dendritic amphiphiles.

Thota BN, Berlepsch HV, Böttcher C, Haag R.

Chem Commun (Camb). 2015 May 21;51(41):8648-51. doi: 10.1039/c4cc09513h.

PMID:
25905112
13.

Dendritic core-shell systems as soft drug delivery nanocarriers.

Lukowiak MC, Thota BN, Haag R.

Biotechnol Adv. 2015 Nov 1;33(6 Pt 3):1327-41. doi: 10.1016/j.biotechadv.2015.03.014. Epub 2015 Apr 11. Review.

PMID:
25868804
14.

Expression patterns of insulin-like growth factor binding protein isoforms in medulloblastoma subtypes and clinical correlation.

Narayan R, Shastry AH, Thota B, Sampath S, Thennarasu K, Arivazhagan A, Santosh V.

Pediatr Neurosurg. 2013;49(6):325-30. doi: 10.1159/000367926. Epub 2014 Nov 22.

PMID:
25427587
15.

STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.

Thota B, Arimappamagan A, Kandavel T, Shastry AH, Pandey P, Chandramouli BA, Hegde AS, Kondaiah P, Santosh V.

J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30.

PMID:
24878287
16.

Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion.

Praveen Kumar VR, Sehgal P, Thota B, Patil S, Santosh V, Kondaiah P.

J Neurooncol. 2014 Feb;116(3):455-64. doi: 10.1007/s11060-013-1324-y. Epub 2014 Jan 7.

PMID:
24395346
17.

A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.

Arimappamagan A, Somasundaram K, Thennarasu K, Peddagangannagari S, Srinivasan H, Shailaja BC, Samuel C, Patric IR, Shukla S, Thota B, Prasanna KV, Pandey P, Balasubramaniam A, Santosh V, Chandramouli BA, Hegde AS, Kondaiah P, Sathyanarayana Rao MR.

PLoS One. 2013 Apr 30;8(4):e62042. doi: 10.1371/journal.pone.0062042. Print 2013.

18.

IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.

Thota B, Shukla SK, Srividya MR, Shwetha SD, Arivazhagan A, Thennarasu K, Chickabasaviah YT, Hegde AS, Chandramouli BA, Somasundaram K, Santosh V.

Am J Clin Pathol. 2012 Aug;138(2):177-84. doi: 10.1309/AJCPZOIY3WY4KIKE.

PMID:
22904127
19.

Expression pattern and prognostic significance of IGFBP isoforms in anaplastic astrocytoma.

Kulkarni A, Thota B, Srividya MR, Thennarasu K, Arivazhagan A, Santosh V, Chandramouli BA.

Pathol Oncol Res. 2012 Oct;18(4):961-7. Epub 2012 May 1.

PMID:
22547392
20.

Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.

Arivazhagan A, Kumar DM, Sagar V, Patric IR, Sridevi S, Thota B, Srividya MR, Prasanna K, Thennarasu K, Mondal N, Hegde AS, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

J Neurooncol. 2012 Apr;107(2):289-97. doi: 10.1007/s11060-011-0758-3. Epub 2011 Nov 19.

PMID:
22102081
21.

Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, Nawaz Z, Prasanna KV, Thennarasu K, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V, Somasundaram K.

J Biol Chem. 2011 Jul 22;286(29):25882-90. doi: 10.1074/jbc.M110.178012. Epub 2011 May 25.

22.

Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients.

Srividya MR, Thota B, Shailaja BC, Arivazhagan A, Thennarasu K, Chandramouli BA, Hegde AS, Santosh V.

Neuropathology. 2011 Aug;31(4):376-83. doi: 10.1111/j.1440-1789.2010.01178.x. Epub 2010 Dec 6.

PMID:
21134002
23.

Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth.

Kumar DM, Thota B, Shinde SV, Prasanna KV, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V, Somasundaram K.

J Proteome Res. 2010 Nov 5;9(11):5557-67. doi: 10.1021/pr1001737. Epub 2010 Sep 28.

PMID:
20822092
24.

Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients.

Srividya MR, Thota B, Arivazhagan A, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Santosh V.

J Clin Pathol. 2010 Aug;63(8):687-91. doi: 10.1136/jcp.2009.074898.

PMID:
20702468
25.

Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.

Ladha J, Donakonda S, Agrawal S, Thota B, Srividya MR, Sridevi S, Arivazhagan A, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Kondaiah P, Somasundaram K, Santosh V, Rao SM.

Cancer Res. 2010 Aug 15;70(16):6437-47. doi: 10.1158/0008-5472.CAN-10-0819. Epub 2010 Jul 27.

26.

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.

Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, Vrinda M, Sridevi S, Shailaja BC, Samuel C, Prasanna KV, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Somasundaram K, Kondaiah P, Rao MR.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213. Epub 2010 May 25.

27.

PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.

Reddy PS, Umesh S, Thota B, Tandon A, Pandey P, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

Cancer Biol Ther. 2008 May;7(5):663-8.

PMID:
18728403
28.

Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.

Reddy SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, Kumari A, Shilpa BM, Vrinda M, Umesh S, Samuel C, Shetty M, Tandon A, Pandey P, Hegde S, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Kondaiah P, Somasundaram K, Rao MR.

Clin Cancer Res. 2008 May 15;14(10):2978-87. doi: 10.1158/1078-0432.CCR-07-4821.

Supplemental Content

Support Center